scholarly journals The Different Dose-Volume Effects of Normal Tissue Complication Probability Using LASSO for Acute Small-Bowel Toxicity during Radiotherapy in Gynecological Patients with or without Prior Abdominal Surgery

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Tsair-Fwu Lee ◽  
Eng-Yen Huang

Purpose. To develop normal tissue complication probability (NTCP) model with least absolute shrinkage and selection operator (LASSO) to analyze dose-volume effects that influence the incidence of acute diarrhea among gynecological patients with/without prior abdominal surgery.Methods and Materials. Ninety-five patients receiving gynecologic radiotherapy (RT) were enrolled. The endpoint was defined as the grade 2+acute diarrhea toxicity during treatment. We obtained the range of small-bowel volume in V4 Gy to V40 Gy of dose.Results. The number of patients experiencing grade 2+acute diarrhea toxicity was 23/61 (38%) in the group without abdominal surgery (group 0) and 17/34 (50%) patients with abdominal surgery (group 1). The most significant predictor was found for the logistic NTCP model with V16 Gy as the cutoff dose for group 0 and V40 Gy for group 1. Logistic regression NTCP model parameters were TV10≈ 290 cc for V16 Gy and TV10≈ 75 cc for V40 Gy, respectively.Conclusion. To keep the incidence of grade 2+acute small-bowel toxicity below 10%, we suggest that small-bowel volume above the prescription dose (V16 Gy) should be held to <290 cc for patients without abdominal surgery, and the prescription dose (V40 Gy) should be maintained <75 cc for patients with abdominal surgery.

2010 ◽  
Vol 76 (3) ◽  
pp. S101-S107 ◽  
Author(s):  
Brian D. Kavanagh ◽  
Charlie C. Pan ◽  
Laura A. Dawson ◽  
Shiva K. Das ◽  
X. Allen Li ◽  
...  

2010 ◽  
Vol 76 (3) ◽  
pp. S145-S150 ◽  
Author(s):  
Søren M. Bentzen ◽  
Matthew Parliament ◽  
Joseph O. Deasy ◽  
Adam Dicker ◽  
Walter J. Curran ◽  
...  

2021 ◽  
Author(s):  
Junichi Fukada ◽  
Kyohei Fukata ◽  
Naoyoshi Koike ◽  
Ryuichi Kota ◽  
Naoyuki Shigematsu

Abstract We investigated the normal tissue complication probability (NTCP) of the incidence of pericardial effusion (PCE) based on the mean heart dose (MHD). We reviewed medical records of oesophageal cancer patients treated with definitive chemoradiotherapy. Incidences of PCE in any grade (A-PCE) and symptomatic PCE (S-PCE) were evaluated separately. To identify significant predictors for PCE, clinical and dose-volume parameters were analysed using a receiver operating characteristic (ROC) curve and multivariate regression analysis. The generated NTCP model was compared to the Lyman–Kutcher–Burman (LKB) model to validate its clinical applicability. Among 229 eligible patients, A-PCE and S-PCE were observed in 100 (43.7%) and 18 (7.9%) patients, respectively. MHD showed a preferable area under the curve (AUC) value for S-PCE (AUC = 0.821) and A-PCE (AUC = 0.734). MHD was the only significant predictor for A-PCE; MHD and hypertension were selected as significant factors for S-PCE. The estimated NTCP, using the MHD-based model, showed excellent correspondence to the LKB model in A-PCE and S-PCE. The NTCP curve of A-PCE was gentler than that of S-PCE and had no threshold. The MHD-based NTCP model was simple but comparable to the LKB model for both A-PCE and S-PCE. Estimated NTCP may provide clinically useful parameters for predicting PCE.


Sign in / Sign up

Export Citation Format

Share Document